Month: July 2020

PARIS, July 16, 2020 (GLOBE NEWSWIRE) — HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdictionThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information,...

16 July 2020, Limassol, CyprusThe Extraordinary General Meeting (the “EGM”) of SeaBird Exploration Plc (“SeaBird”) is completed. All proposals on the agenda, as proposed by the board of directors and set out in the notice of the meeting announced on 1 July 2020, were adopted with requisite majority.After the EGM, SeaBird’s board of directors consists of Mr. Ståle Rodahl (Chairman), Mr. Nicholas Knag Nunn, Mr. Øivind Dahl-Stamnes, Mr. Rolf Inge Jacobsen and Mr. Hans Christian Anderson and SeaBird’s nomination committee consists of Mr. Svein Øvrebø, Mr. Per Øyvind Berge and Mr. Hans Jan Henry Anderson.SeaBird is a global provider of marine acquisition for 2D/3D and 4D seismic data, and associated products and services to the oil and gas industry. SeaBird specializes in high quality operations within the...

SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced the filing of the pivotal ENVASARC protocol with the U.S. Food and Drug Administration (FDA) as part of an Investigational New Drug (IND) application. The application cross references the open envafolimab IND maintained by TRACON’s corporate partners 3D Medicines and Alphamab Oncology.TRACON previously reported results of a May 8 teleconference with the FDA whereby the agency agreed with TRACON’s proposals regarding key elements of the...

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (Frankfurt: B4IE) (the “Company” or “Goliath”) is pleased to announce a non-brokered flow through financing and strategic investment from a syndicate led by Palisades Goldcorp Ltd. (“Palisades”). The financing will also consist of a non flow-through component.“We are extremely pleased to welcome Palisades Goldcorp as a strategic investor in Goliath” said Roger Rosmus, President and Chief Executive Officer. “Palisades Goldcorp’s strategic investment is a strong endorsement of the upside value they currently see in relation to our properties located in the prolific Abitibi Greenstone Belt and Golden Triangle that are well established gold districts. We look forward to the advancement of our projects as we work towards delivering value to...

CONWAY, Ark., July 16, 2020 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NASDAQ GS: HOMB), parent company of Centennial Bank, released second quarter earnings today, that reveal a solid foundation of earnings and asset quality during the first full quarter of the pandemic.Highlights of the Second Quarter of 2020:(1) Calculation of this metric and the reconciliation to GAAP are included in the schedules accompanying this release.“To say that during a full quarter of a pandemic that HOMB was able to meet EPS targets, set a record for revenue and maintain a solid net interest margin brings about an enormous sense of pride that I have in this team of bankers,” said John Allison, Chairman. “Our outlook for future dividends remains strong, which is also an important component to our solid performance,” Allison continued.“While we realize...

The Supervisory Board of Admiral Markets AS intends to appoint Victor Gherbovet as a new Management Board Member from 27.07.2020. Admiral Markets AS shall as of 27.07.2020 have four Management Board Members: Sergei Bogatenkov, Victor Gherbovet, Dmitri Lauš and Jens Chrzanowski.The changes in the Management Board are due to the long-term strategy of Admiral Markets AS and the desire to increase the company’s presence in new global markets.Additional information:Kaia GilCommunication manager of Admiral Markets ASkaia.gil@admiralmarkets.com+372 53 413 764 

Admiral Markets AS-i nõukogu kavatseb nimetada Victor Gherboveti ühingu juhatuse liikmeks alates 27.07.2020. Admiral Markets AS-i juhatusse kuuluvad alates 27.07.2020 neli liiget: Sergei Bogatenkov, Victor Gherbovet, Dmitri Lauš ja Jens Chrzanowski. Muudatused juhatuses tulenevad Admiral Markets AS-i pikaajalisest strateegiast ja soovist kasvatada ettevõtte kohalolekut uutel turgudel.Victor Gherbovet liitus ettevõttega 2008. aastal ning ta kuulub Admiral Markets Group AS juhatusse alates 2017.aastast.Lisainfo: Kaia GilAdmiral Markets AS-i kommunikatsioonijuhtkaia.gil@admiralmarkets.com+372 53 413 764

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Amarillo Gold Corporation (Amarillo or the Company) (TSXV: AGC, OTCQB: AGCBF) has achieved another major milestone on its project development schedule for its flagship Posse Gold Project in Goiás State, Brazil. The Company has received a Water Use Permit for its proposed mine from the country’s National Water Agency. Receiving this permit is a precondition to receiving the License to Install, expected in the third quarter of 2020.“This is the next step on our path to construction,” said Mike Mutchler, Amarillo’s Chief Executive Officer. “We are working with Auramet International on construction financing and are on track to starting detailed engineering and execution planning in the third quarter. We are also targeting procurement for long lead items to start in the fourth quarter of this...

MONTRÉAL, 16 juill. 2020 (GLOBE NEWSWIRE) — ATW Tech Inc. (la « Société ») (TSX-V : ATW) annonce aujourd’hui ses résultats pour son exercice terminé le 31 décembre 2019.La Société a généré des revenus de 5,7m$ en 2019 comparativement à 11,9m$ en 2018, soit une diminution de 6,2m$ ou 52%.  Le coût des ventes a totalisé 5,0m$ en 2019 comparativement à 9,8m$ en 2018, soit une diminution de 4,8m$ ou 49% pour une marge (excluant amortissement) de 0,7m$ en 2019 ou 11,9% comparativement à 2m$ ou 17% en 2018.Le 31 juillet 2019, la Société a conclu la vente d’actifs de sa division VuduMobile pour un prix de 1,35m$ dont 1,15m$ a été payé en espèces et 0,2m$ en compensation de dettes fournisseurs, pour un gain sur disposition de 0,7m$.Le 12 février 2020, la Société a annoncé la conversion, par Groupe Gestion G5 Inc., de son prêt convertible...

MELBOURNE, Australia, July 16, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale in a registered direct offering of 1,025,000 American Depositary Shares (“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at a purchase price of $5.00 per ADS. The closing of the offering is expected to occur on or about July 20, 2020, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds to the Company from this offering are expected to be approximately $5.1 million, before deducting...